Redhill Biopharma Stock Market Value
| RDHL Stock | USD 6.74 0.34 5.31% |
| Symbol | Redhill |
Redhill Biopharma Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (302.63) | Revenue Per Share 4.733 | Quarterly Revenue Growth (0.28) | Return On Assets (0.45) | Return On Equity (17.09) |
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Redhill Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Redhill Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Redhill Biopharma.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Redhill Biopharma on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Redhill Biopharma or generate 0.0% return on investment in Redhill Biopharma over 30 days. Redhill Biopharma is related to or competes with Organogenesis Holdings, Lifecore Biomedical, Collegium Pharmaceutical, Aquestive Therapeutics, Evoke Pharma, Petros Pharmaceuticals, and Cumberland Pharmaceuticals. RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious dise... More
Redhill Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Redhill Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Redhill Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 29.17 | |||
| Value At Risk | (9.00) | |||
| Potential Upside | 7.06 |
Redhill Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Redhill Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Redhill Biopharma's standard deviation. In reality, there are many statistical measures that can use Redhill Biopharma historical prices to predict the future Redhill Biopharma's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (1.27) | |||
| Treynor Ratio | (1.52) |
Redhill Biopharma Backtested Returns
Redhill Biopharma maintains Sharpe Ratio (i.e., Efficiency) of -0.05, which implies the firm had a -0.05% return per unit of risk over the last 3 months. Redhill Biopharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Redhill Biopharma's Coefficient Of Variation of (831.95), variance of 25.42, and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide. The company holds a Beta of 0.41, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Redhill Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Redhill Biopharma is expected to be smaller as well. At this point, Redhill Biopharma has a negative expected return of -0.24%. Please make sure to check Redhill Biopharma's skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Redhill Biopharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.5 |
Modest reverse predictability
Redhill Biopharma has modest reverse predictability. Overlapping area represents the amount of predictability between Redhill Biopharma time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Redhill Biopharma price movement. The serial correlation of -0.5 indicates that about 50.0% of current Redhill Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.29 |
Redhill Biopharma lagged returns against current returns
Autocorrelation, which is Redhill Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Redhill Biopharma's stock expected returns. We can calculate the autocorrelation of Redhill Biopharma returns to help us make a trade decision. For example, suppose you find that Redhill Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Redhill Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Redhill Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Redhill Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Redhill Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Redhill Biopharma Lagged Returns
When evaluating Redhill Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Redhill Biopharma stock have on its future price. Redhill Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Redhill Biopharma autocorrelation shows the relationship between Redhill Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Redhill Biopharma.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Redhill Biopharma Correlation, Redhill Biopharma Volatility and Redhill Biopharma Alpha and Beta module to complement your research on Redhill Biopharma. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Redhill Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.